Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer.

Frontiers in immunology - 1 Jan 2021

Liang Hongge, Xu Yan, Chen Minjiang, Zhao Jing, Zhong Wei, Liu Xiaoyan, Gao Xiaoxing, Li Shanqing, Li Ji, Guo Chao, Jia He, Wang Mengzhao

Abstract excerpt

Purpose: Immune checkpoint inhibitors (ICIs) have recently emerged as an important option for treating patients with advanced non-small cell lung cancer (NSCLC). Neoantigens are important biomarkers and potential immunotherapy targets that play important roles in the prognosis and treatment of patients with NSCLC. This study aimed to evaluate and characterize the relationships between somatic mutations and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Immunotherapy and Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Immunotherapy and Immune Responses

Share to Lung Neoplasms

Share to Mutation

Share to vaccines and immunoinformatics approaches

Source

Open in PubMed Open full text

Identifiers

PMID: 35356154
DOI: 10.3389/fimmu.2021.749461
PMCID: PMC8959482

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer.PMID 35356154Read ↗

Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer.Semantic proximity Read ↗

Neoantigen Load as a Prognostic and Predictive Marker for Stage II/III Non-Small Cell Lung Cancer in Chinese PatientsSemantic proximity Read ↗

Sources of Cancer Neoantigens beyond Single-Nucleotide Variants.Semantic proximity Read ↗

Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and ProspectsSemantic proximity Read ↗

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and ImmunotherapySemantic proximity Read ↗

Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole‐exome sequencingSemantic proximity Read ↗

The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space.Semantic proximity Read ↗

The Current Lung Cancer Neoantigen Landscape and Implications for Therapy.Semantic proximity Read ↗

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine designSemantic proximity Read ↗

Immunopeptidomics-guided identification of functional neoantigens in non-small cell lung cancerSemantic proximity Read ↗

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma.Semantic proximity Read ↗

Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.